Back to search
ALK Fusion-positive Solid or CNS Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ALK Fusion-positive Solid or CNS Tumors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which ALK Fusion-positive Solid or CNS Tumors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Currently, tyrosine kinase inhibitor (TKI) remains the standard of care for oncogene-driven non-small cell lung cancer (NSCLC). However, almost all oncogene-dri…
This study will evaluate the efficacy and safety of alectinib in participants with Anaplastic Lymphoma Kinase (ALK)-positive locally advanced or metastatic soli…